You are here: Industry Insights > Abbott

News List

Abbott India Q4FY20 performance hit by COVID 19 impact: ICICI Securities expresspharma
June 10, 2020
“We have reduced our revenue and EPS estimates for FY21E-FY22E by 4-5 per cent and 12-14 per cent to factor COVID-19 impact and lower other income,” commented the capital market company on the pharma company’s financial performance for the quarter.
Abbott Releases Interim Study Data on ID NOW COVID-19 Rapid Test americanpharmaceuticalreview
May 28, 2020
Abbott announced an interim analysis of an ongoing multi-site clinical study in urgent care clinics that indicates its ID NOW COVID-19 rapid test is showing strong agreement to lab-based molecular polymerase chain reaction (PCR) instruments.
FDA Warns of Possible Accuracy Concerns with Abbott ID NOW Test americanpharmaceuticalreview
May 18, 2020
The U.S. Food and Drug Administration (FDA) is alerting the public to early data that suggest potential inaccurate results from using the Abbott ID NOW point-of-care test to diagnose COVID-19. Specifically, the test may return false negative results.
Abbott Receives EUA for COVID-19 Antibody Blood Test on Alinity i System americanpharmaceuticalreview
May 15, 2020
Abbott announced the U.S. Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) for the company's SARS-CoV-2 IgG lab-based serology blood test on the Alinity™ i system.
Abbott launches COVID-19 lab-based antibody test pharmatimes
May 06, 2020
Abbott has announced the immediate availability of its lab-based antibody test for COVID-19 after it was granted a CE Mark.
Abbott Launches Third COVID-19 Test contractpharma
April 16, 2020
Begins shipping April 16 and intends to distribute 4 million tests in April, ramping to 20 million in the U.S. per month in June and beyond.
Abbott to Deploy Rapid COVID-19 Test in NJ contractpharma
April 02, 2020
Gov. Phil Murphy says Bergen County selected as first testing site; results delivered in as little as five minutes.
U.S. Approves Abbott Labs Coronavirus Test For Hospital Use forbes
March 20, 2020
Abbott Laboratories won U.S. approval for its molecular test for the Coronavirus strain COVID-19, which will be used by hospitals and academic medical centers to speed diagnostic capabilities ...
Abbott's RealTime SARS-CoV-2 Test Receives EUA contractpharma
March 20, 2020
System uses polymerase chain reaction (PCR) technology and has the ability to run high volumes of up to 470 tests in 24 hours.
Sanofi, Abbott team up to enhance diabetes management biospectrumasia
September 17, 2019
Collaboration aims to provide a connected device experience for millions of people living with diabetes using insulin

Previous page 1 2 3 4 5 6 7 Next page